SEC Filing Details
Document Details
Form
Filing Date
Nov 8, 2024
Document Date
Sep 30, 2024
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Akero Therapeutics, Inc.
Issuer
Akero Therapeutics, Inc.